4-Methylcatechol-induced oxidative stress induces intrinsic apoptotic pathway in metastatic melanoma cells

Florastina Payton, Rumu Bose, William L. Alworth, Addanki P Kumar, Rita Ghosh

Research output: Contribution to journalArticle

11 Citations (Scopus)

Abstract

There has been a steady rise in fatalities associated with thick melanomas (>4 mm). Although understanding of the biology of the disease has improved, effective treatment strategies for patients with advanced metastatic melanoma remain elusive. Therefore, more intensive testing of agents with therapeutic potential are needed to improve survival of patients with metastatic malignant melanoma. We have tested the ability of 4-methylcatechol, a metabolite of quercetin; a naturally occurring compound that is commonly found in a variety of fruits for its potential as an anti-melanoma agent. Our results show that 4-methylcatechol inhibits proliferation of melanoma cells in culture while not affecting the growth of normal human epidermal melanocytes. Further, the ability of metastatic melanoma cells to form colonies on soft agar was also inhibited. 4-Methylcatechol caused the accumulation of cells in G2/M phase of the cell cycle and induced apoptosis. There was an increase in reactive oxygen species following treatment with 4-methylcatechol that led to apoptosis through the intrinsic mitochondrial pathway. Treatment also inhibited cell survival mediated by Akt, a key player in melanoma cell survival. Taken together our results suggest that 4-methylcatechol exhibits cytotoxicity towards metastatic malignant melanoma cells while sparing normal melanocytes and should be tested further as a potential drug candidate for malignant melanoma.

Original languageEnglish (US)
Pages (from-to)1211-1218
Number of pages8
JournalBiochemical Pharmacology
Volume81
Issue number10
DOIs
StatePublished - May 15 2011

Fingerprint

Oxidative stress
Melanoma
Oxidative Stress
Cells
Apoptosis
Melanocytes
Quercetin
Cytotoxicity
Metabolites
Fruits
Cell Survival
Agar
Reactive Oxygen Species
4-methylcatechol
G2 Phase
Therapeutics
Testing
Cell Division
Pharmaceutical Preparations
Fruit

Keywords

  • 4-Methylcatechol
  • Apoptosis
  • Cell cycle arrest
  • Melanoma
  • Reactive oxygen species
  • Survival

ASJC Scopus subject areas

  • Pharmacology
  • Biochemistry

Cite this

4-Methylcatechol-induced oxidative stress induces intrinsic apoptotic pathway in metastatic melanoma cells. / Payton, Florastina; Bose, Rumu; Alworth, William L.; Kumar, Addanki P; Ghosh, Rita.

In: Biochemical Pharmacology, Vol. 81, No. 10, 15.05.2011, p. 1211-1218.

Research output: Contribution to journalArticle

@article{d9e14d891caf4d329c89debf0e59e80e,
title = "4-Methylcatechol-induced oxidative stress induces intrinsic apoptotic pathway in metastatic melanoma cells",
abstract = "There has been a steady rise in fatalities associated with thick melanomas (>4 mm). Although understanding of the biology of the disease has improved, effective treatment strategies for patients with advanced metastatic melanoma remain elusive. Therefore, more intensive testing of agents with therapeutic potential are needed to improve survival of patients with metastatic malignant melanoma. We have tested the ability of 4-methylcatechol, a metabolite of quercetin; a naturally occurring compound that is commonly found in a variety of fruits for its potential as an anti-melanoma agent. Our results show that 4-methylcatechol inhibits proliferation of melanoma cells in culture while not affecting the growth of normal human epidermal melanocytes. Further, the ability of metastatic melanoma cells to form colonies on soft agar was also inhibited. 4-Methylcatechol caused the accumulation of cells in G2/M phase of the cell cycle and induced apoptosis. There was an increase in reactive oxygen species following treatment with 4-methylcatechol that led to apoptosis through the intrinsic mitochondrial pathway. Treatment also inhibited cell survival mediated by Akt, a key player in melanoma cell survival. Taken together our results suggest that 4-methylcatechol exhibits cytotoxicity towards metastatic malignant melanoma cells while sparing normal melanocytes and should be tested further as a potential drug candidate for malignant melanoma.",
keywords = "4-Methylcatechol, Apoptosis, Cell cycle arrest, Melanoma, Reactive oxygen species, Survival",
author = "Florastina Payton and Rumu Bose and Alworth, {William L.} and Kumar, {Addanki P} and Rita Ghosh",
year = "2011",
month = "5",
day = "15",
doi = "10.1016/j.bcp.2011.03.005",
language = "English (US)",
volume = "81",
pages = "1211--1218",
journal = "Biochemical Pharmacology",
issn = "0006-2952",
publisher = "Elsevier Inc.",
number = "10",

}

TY - JOUR

T1 - 4-Methylcatechol-induced oxidative stress induces intrinsic apoptotic pathway in metastatic melanoma cells

AU - Payton, Florastina

AU - Bose, Rumu

AU - Alworth, William L.

AU - Kumar, Addanki P

AU - Ghosh, Rita

PY - 2011/5/15

Y1 - 2011/5/15

N2 - There has been a steady rise in fatalities associated with thick melanomas (>4 mm). Although understanding of the biology of the disease has improved, effective treatment strategies for patients with advanced metastatic melanoma remain elusive. Therefore, more intensive testing of agents with therapeutic potential are needed to improve survival of patients with metastatic malignant melanoma. We have tested the ability of 4-methylcatechol, a metabolite of quercetin; a naturally occurring compound that is commonly found in a variety of fruits for its potential as an anti-melanoma agent. Our results show that 4-methylcatechol inhibits proliferation of melanoma cells in culture while not affecting the growth of normal human epidermal melanocytes. Further, the ability of metastatic melanoma cells to form colonies on soft agar was also inhibited. 4-Methylcatechol caused the accumulation of cells in G2/M phase of the cell cycle and induced apoptosis. There was an increase in reactive oxygen species following treatment with 4-methylcatechol that led to apoptosis through the intrinsic mitochondrial pathway. Treatment also inhibited cell survival mediated by Akt, a key player in melanoma cell survival. Taken together our results suggest that 4-methylcatechol exhibits cytotoxicity towards metastatic malignant melanoma cells while sparing normal melanocytes and should be tested further as a potential drug candidate for malignant melanoma.

AB - There has been a steady rise in fatalities associated with thick melanomas (>4 mm). Although understanding of the biology of the disease has improved, effective treatment strategies for patients with advanced metastatic melanoma remain elusive. Therefore, more intensive testing of agents with therapeutic potential are needed to improve survival of patients with metastatic malignant melanoma. We have tested the ability of 4-methylcatechol, a metabolite of quercetin; a naturally occurring compound that is commonly found in a variety of fruits for its potential as an anti-melanoma agent. Our results show that 4-methylcatechol inhibits proliferation of melanoma cells in culture while not affecting the growth of normal human epidermal melanocytes. Further, the ability of metastatic melanoma cells to form colonies on soft agar was also inhibited. 4-Methylcatechol caused the accumulation of cells in G2/M phase of the cell cycle and induced apoptosis. There was an increase in reactive oxygen species following treatment with 4-methylcatechol that led to apoptosis through the intrinsic mitochondrial pathway. Treatment also inhibited cell survival mediated by Akt, a key player in melanoma cell survival. Taken together our results suggest that 4-methylcatechol exhibits cytotoxicity towards metastatic malignant melanoma cells while sparing normal melanocytes and should be tested further as a potential drug candidate for malignant melanoma.

KW - 4-Methylcatechol

KW - Apoptosis

KW - Cell cycle arrest

KW - Melanoma

KW - Reactive oxygen species

KW - Survival

UR - http://www.scopus.com/inward/record.url?scp=79955472023&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=79955472023&partnerID=8YFLogxK

U2 - 10.1016/j.bcp.2011.03.005

DO - 10.1016/j.bcp.2011.03.005

M3 - Article

C2 - 21419106

AN - SCOPUS:79955472023

VL - 81

SP - 1211

EP - 1218

JO - Biochemical Pharmacology

JF - Biochemical Pharmacology

SN - 0006-2952

IS - 10

ER -